EDAP TMS S.A. (EDAP) is a holding company. The Company is engaged in developing and marketing the Ablatherm and Focal One devices for high intensity focused ultrasound (HIFU) treatment of localized prostate cancer. It operates two divisions: High Intensity Focused Ultrasound and urology Devices and Services (UDS) (including lithotripsy activities). Through these two divisions, the Company develops, produces and markets medical devices, mainly for urological diseases. The Company’s HIFU and UDS divisions operate in Europe, the Americas, Asia and the rest of the world. It is developing HIFU technology for the treatment of certain other types of tumors. It also produces and commercializes medical equipment for treatment of urinary tract stones using